Spero Therapeutics Inc (SPRO)
1.405
-0.06
(-4.42%)
USD |
NASDAQ |
Apr 19, 16:00
1.40
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Profit Margin (Quarterly): 71.27% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 71.27% |
| September 30, 2023 | -13.71% |
| June 30, 2023 | -1.51K% |
| March 31, 2023 | -1.79K% |
| December 31, 2022 | 57.75% |
| September 30, 2022 | -1.08K% |
| June 30, 2022 | -3.20K% |
| March 31, 2022 | -13.29K% |
| December 31, 2021 | -11.42K% |
| September 30, 2021 | -3.18K% |
| June 30, 2021 | -881.9% |
| March 31, 2021 |
| Date | Value |
|---|---|
| December 31, 2020 | |
| September 30, 2020 | -474.0% |
| June 30, 2020 | -1.01K% |
| March 31, 2020 | -1.37K% |
| December 31, 2019 | |
| September 30, 2019 | -381.6% |
| June 30, 2019 | -609.9% |
| March 31, 2019 | -133.2% |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | -2.15K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-13.29K%
Minimum
Mar 2022
71.27%
Maximum
Dec 2023
-2.51K%
Average
-1.05K%
Median
Profit Margin (Quarterly) Benchmarks
| Retractable Technologies Inc | -0.51% |
| OptiNose Inc | -50.17% |
| scPharmaceuticals Inc | -226.6% |
| electroCore Inc | -77.67% |
| Equillium Inc | -25.43% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 32.02% |
| Return on Assets | 18.22% |
| Return on Invested Capital | 32.02% |
| Operating Margin (Quarterly) | 70.35% |
| Return on Net Operating Assets | 135.4% |